Pediatrix Medical Group (NYSE:MD) Stock Price Expected to Rise, Truist Financial Analyst Says

Pediatrix Medical Group (NYSE:MD) had its price objective boosted by Truist Financial from $17.00 to $24.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “hold” rating on the stock. Truist Financial’s target price points to a potential upside of 7.62% from the stock’s previous close.

Several other equities research analysts also recently weighed in on MD. Weiss Ratings reissued a “hold (c)” rating on shares of Pediatrix Medical Group in a research report on Wednesday, October 8th. Leerink Partners lifted their target price on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. UBS Group boosted their price target on Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a “neutral” rating in a research note on Wednesday. Zacks Research downgraded Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 7th. Finally, Wall Street Zen upgraded Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 4th. One investment analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $19.80.

Pediatrix Medical Group Stock Up 1.7%

Shares of MD traded up $0.37 during trading hours on Monday, hitting $22.30. The company had a trading volume of 443,409 shares, compared to its average volume of 773,784. The stock has a market capitalization of $1.92 billion, a price-to-earnings ratio of 17.29 and a beta of 1.20. The firm has a fifty day moving average price of $17.29 and a 200-day moving average price of $15.16. Pediatrix Medical Group has a 52-week low of $11.84 and a 52-week high of $22.52. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.46 by $0.21. The company had revenue of $492.88 million for the quarter, compared to the consensus estimate of $476.45 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. Pediatrix Medical Group’s revenue for the quarter was down 3.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.44 EPS. On average, equities research analysts forecast that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Hillsdale Investment Management Inc. increased its position in shares of Pediatrix Medical Group by 20.1% during the 3rd quarter. Hillsdale Investment Management Inc. now owns 452,200 shares of the company’s stock valued at $7,574,000 after purchasing an additional 75,700 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its holdings in shares of Pediatrix Medical Group by 25.8% in the third quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 14,989 shares of the company’s stock worth $251,000 after buying an additional 3,076 shares during the last quarter. JPMorgan Chase & Co. grew its position in Pediatrix Medical Group by 20.5% during the third quarter. JPMorgan Chase & Co. now owns 827,075 shares of the company’s stock valued at $13,854,000 after buying an additional 140,577 shares during the period. PNC Financial Services Group Inc. increased its holdings in Pediatrix Medical Group by 4.5% during the third quarter. PNC Financial Services Group Inc. now owns 14,525 shares of the company’s stock valued at $243,000 after buying an additional 631 shares during the last quarter. Finally, Public Sector Pension Investment Board raised its position in Pediatrix Medical Group by 42.7% in the third quarter. Public Sector Pension Investment Board now owns 409,678 shares of the company’s stock worth $6,862,000 after acquiring an additional 122,618 shares during the period. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.